
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor wi... Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0665 | -7.47191011236 | 0.89 | 0.909 | 0.75 | 71509 | 0.83482032 | CS |
4 | -0.5365 | -39.4485294118 | 1.36 | 1.4 | 0.75 | 146105 | 1.05193733 | CS |
12 | -0.6015 | -42.2105263158 | 1.425 | 3.3 | 0.75 | 1737575 | 2.15733961 | CS |
26 | -2.8315 | -77.4692202462 | 3.655 | 4.318 | 0.75 | 819966 | 2.19647658 | CS |
52 | -5.1765 | -86.275 | 6 | 9.09 | 0.75 | 686727 | 3.78750997 | CS |
156 | -689.1765 | -99.8806521739 | 690 | 1147.5 | 0.75 | 1974218 | 103.89917488 | CS |
260 | -6749.1765 | -99.9878 | 6750 | 8182.5 | 0.75 | 1704564 | 324.31628713 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.